Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Forex

ResMed Inc. Stock Surges After RBC Upgrade

Guavy AI Editorial Team
Instruments
CAD
Share

ResMed Inc.'s stock has seen a significant boost after Royal Bank of Canada upgraded its rating from Sector Perform to Outperform and increased its price target to $262.00.

The upgrade is based on ResMed's recent financial performance, with the company delivering robust fourth-quarter earnings that justify the new RBC target.

Management has also provided guidance for fiscal 2027, expecting currency-adjusted core revenue to grow by 5 percent to 7 percent and core earnings per share to increase by 12 percent to 14 percent.

The spread between revenue and earnings growth indicates a planned improvement in margins as scale benefits and product mix changes flow through the income statement.

More on Forex

Forex 3m ago

Bank of England Keeps Interest Rates Unchanged Amid Rising Inflation Concerns

Forex 5m ago

Fed Raises Interest Rates Amid Inflation Concerns, Despite Ongoing War

Forex 6m ago

Fed Rate Hike May Not Bind China's Monetary Easing Options

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy